Dr. Cuartero Samperi Rafael
Orthoptist / Assistant in Ophthalmology
Linea di ricerca: Medical and surgical retina
Unità di ricerca: UR Medical Retina
Unità Operativa Semplice: UOS Retina Medica, low vision and visual rehabilitation
Principali specializzazioni: DIABETIC RETINOPATHY, AGE-RELATED MACULAR DEGENERATION (AMD), REFRACTIVE ERRORS, LOW VISION AND VISUAL REHABILITATION, RETINAL VEIN OCCLUSION, RETINAL DETACHMENT
Medical activity: Since 2018 Dr. Cuartero Samperi Rafael has been working for Medical Retinal Unit “Fondazione G.B.Bietti-IRCCS” in clinical-scientific activities in the offices of Via Livenza, 3 and Via di Santo Stefano Rotondo 6, Rome. Mainly he works for many clinical trials as Study- cordinator , Data Entry and Technician. His main interests concern retina deseases , Low vision and Visual Rehabilitation and Instrumental diagnostic tests for Retinal deseases.
In 2016: Degree in “Orthoptics and Assistance in Ophtalmology” – Universita’ degli Studi di ROMA ‘Tor Vergata’, Roma (Italy)
Since 2018 Employed at IRCCS Fondazione G.B.Bietti, Medical Retinal Unit
- Evidence of Anti-VEGF use in real Life Experience – A retrospective cohort study from secondary data source in Italy – Chart Review. (EAGLE STUDY)
- Valutazione di un regime di dosaggio prolungato e proattivo in pazienti naïve al trattamento con degenerazione maculare senile umida, wamd. (XTEND STUDY).
- Retinal and cognitive dysfunction in type 2 diabetes: unravelling the common pathways and identification of patients at risk of dementia. (RECOGNISED STUDY)
- Patient Experience and Preference (PEP) Study in nAMD and DME
Study Protocol – MR41928 (PEP STUDY)
- A longitudinal, biomarker study of anti-vegf to explore the raltionship between aqueous humor composition and multimodal retinal imaging in neovascular age-related macular degeneration and diabetic macular edema. ( LONGITUDE STUDY).
- Valutazione della soddisfazione del paziente nella gestione della degenerazione maculare legata all’età in forma umida (wet Age-Related Macular Degeneration – wAMD): survey sui pazienti italiani (SWAN STUDY)
- Rwe study of anti-vegf therapies in neovascular age related macular degeneration in Italy: adherence, needs,cost and effectiveness analysis. (Studio ML 43 667 RADIANCE)